Akso Health Group ADS (AHG) Financials

$0.84

$0.11 (14.93%)

As on 11-Sep-2026 16:00EDT

Market cap

$726 Mln

Revenue (TTM)

$14 Mln

P/E Ratio

--

P/B Ratio

4.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	13.83	14.78	2.41	13.18	6.31	1.75
Cost of Revenue	13.84	15.06	2.29	11.91	5.39	0.54
Gross Profit	-0.01	-0.28	0.12	1.27	0.92	1.21
Operating Expenses	3.99	166.02	8.76	15.54	16.05	28.36
Operating Profit (EBIT)	-4.00	-166.30	-8.64	-14.27	-15.13	-27.15
Other Income	--	--	--	--	--	--
Profit before Tax	-20.70	-166.27	-9.09	-13.07	-16.72	-3.81
Provision for Tax	-1.99	-30.80	0.02	0.02	0.13	0.48
Profit after Tax (Net Income)	-18.67	-134.98	-9.46	-1.36	-16.85	-34.83
Minority Interest	0.04	0.49	0.06	-0.11	0.00	--
Consolidated Profit	--	--	--	-1.36	-16.85	-34.83

Liabilities ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	180.93	199.12	138.37	8.73	12.29	17.27
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.00	1.99	0.42	11.62	--	4.41
Current Liabilities	8.71	13.81	3.59	11.62	38.39	14.41
Total Liabilities	189.63	214.95	142.02	20.46	50.68	31.69

Assets ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	0.09	18.83	0.40	0.18	0.06	1.56
Current Assets	189.55	196.12	142.02	20.46	50.62	30.12
Total Assets	189.63	214.95	142.02	20.46	50.68	31.69
Total Debt*	0.38	0.08	2.00	9.69	--	10.00
Net Current Assets	180.84	182.31	138.42	9.11	12.23	15.71

Cashflow ($ Mln)	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	-12.79	1.18	1.35	-3.25	-8.63	10.06
Cash Flow from Investing Activities	-163.46	-105.91	-54.72	18.47	-19.96	0.00
Cash from Financing Activities	0.35	195.88	131.65	-27.51	34.78	-9.04
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS ($)	-0.07	-0.40	-0.40	-0.18	-2.54	-0.71
Cash EPS ($)	-0.06	-0.39	-0.40	-0.18	-2.54	-0.71
Adjusted Book Value ($)	0.63	0.59	5.81	1.14	1.86	0.35
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.04	0.00	0.06	-0.43	-1.30	0.21
Free Cash Flow per Share ($)	-0.66	0.00	0.06	-0.43	-1.30	0.21

Profitability Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	-9.81	-79.50	-11.91	-8.86	-85.19	-72.46
ROE (%)	-9.83	-79.99	-12.86	-12.94	-114.01	-106.55
ROA (%)	-9.23	-75.62	-11.64	-3.82	-40.91	-62.10
EBIT Margin (%)	-28.92	-26.55	-715.56	-108.37	-239.79	-1,647.62
Net Margin (%)	-134.99	-913.38	-391.78	-10.32	-266.99	-1,984.52
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-0.06	5.12	-0.82	1.09	2.60	-0.75
EBIT Growth (%)	-1.96	77.29	-20.94	5.61	47.66	34.84
Net Profit Growth (%)	86.17	-1,327.01	-595.54	91.93	51.62	51.08
EPS Growth (%)	0.84	-0.01	-1.23	0.93	-2.57	0.84
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-34.86	-2.95	-2.92	-1.99	-0.66	-2.47
Price / Book Value	3.60	2.00	0.20	0.31	0.91	4.98
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-399.77	-125.04	6.43	-0.31	0.68	-2.80
Close Price ($)	2.28	1.18	1.16	0.36	1.69	1.76
High Price ($)	2.50	2.35	2.90	1.85	22.39	7.44
Low Price ($)	0.83	0.60	0.25	0.20	1.23	0.97
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.00	0.00	0.01	1.11	--	0.58
Short term debt to equity ratio	0.00	0.00	0.01	1.11	--	0.58
Current Ratio	21.77	14.20	39.52	1.76	1.32	2.09
Quick Ratio	21.74	14.18	39.46	1.62	1.12	3.09
Interest Coverage	--	--	--	-17.76	-18.82	-13.42

Operating Efficiency Ratios	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	9.26	87.26	2,329.83	69.99	317.18	820.60
Asset Turnover	0.07	0.08	0.03	0.37	0.15	0.03
Receivable days	187.18	854.51	4,952.72	405.15	995.97	5,272.25
Inventory Days	5.15	4.63	149.60	145.37	-222.64	-13,082,401.96
Payable days	--	-48.51	-931.06	-296.99	--	--
Cash Conversion Cycle	--	907.64	6,033.38	847.51	--	--